Centre for Commercialization of Regenerative Medicine:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centre for Commercialization of Regenerative Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9418
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre for Commercialization of Regenerative Medicine (CCRM) is a healthcare service provider that offers cell reprogramming and engineering, cell manufacturing, biomaterials and devices manufacturing, and protocol development services. The center harnesses the power of stem cells, biomaterials and molecules to repair, regenerate or replace diseased cells, tissues and organs. It provides business, scientific and technical services for its partners in regenerative medicine field. CCRM offers novel solutions in cell and vector process development and optimization, media formulation and development, genome editing, pluripotent stem cells and cell-based immunotherapies, among others. The center supports its partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. CCRM is headquartered in Toronto, Ontario, Canada.

Centre for Commercialization of Regenerative Medicine – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Centre for Commercialization of Regenerative Medicine and Affigen Enter into Partnership 10
Hemostemix Enters into Co-Development Agreement with Commercialization of Regenerative Medicine 11
EMD Millipore Enters Into Co-Development Agreement With Centre for Commercialization of Regenerative Medicine 12
Centre for Commercialization of Regenerative Medicine – Key Competitors 13
Centre for Commercialization of Regenerative Medicine – Key Employees 14
Centre for Commercialization of Regenerative Medicine – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Key Facts 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Commercialization of Regenerative Medicine, Deals By Therapy Area, 2012 to YTD 2018 8
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centre for Commercialization of Regenerative Medicine and Affigen Enter into Partnership 10
Hemostemix Enters into Co-Development Agreement with Commercialization of Regenerative Medicine 11
EMD Millipore Enters Into Co-Development Agreement With Centre for Commercialization of Regenerative Medicine 12
Centre for Commercialization of Regenerative Medicine, Key Competitors 13
Centre for Commercialization of Regenerative Medicine, Key Employees 14

List of Figures
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centre for Commercialization of Regenerative Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Centre for Commercialization of Regenerative Medicine:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oragenics Inc (OGEN):企業の財務・戦略的SWOT分析
    Oragenics Inc (OGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • NovaDigm Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary NovaDigm Therapeutics Inc (NovaDigm) is a developer of immunotherapeutics and preventative vaccines to protect patients from fungal and bacterial diseases. The company’s products include NDV-3 vaccines, ALS3 vaccines, vaccine clinical supplies, bacterial and fungal vaccine antigens, vaginal …
  • First Pacific Co Ltd (142):企業の財務・戦略的SWOT分析
    First Pacific Co Ltd (142) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Enel SpA (ENEL)-石油・ガス分野:企業M&A・提携分析
    Summary Enel S.p.A. (Enel) is an energy group that produces, distributes and trades electricity and natural gas. The group generates electricity using diverse sources of energy such as nuclear, renewables, oil and gas turbine, coal and gas combined cycle. It also focuses on digitizing electricity gr …
  • Merck & Co Inc (MRK):企業の財務・戦略的SWOT分析
    Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Garden Fresh Restaurants, LLC:企業の戦略・SWOT・財務分析
    Garden Fresh Restaurants, LLC - Strategy, SWOT and Corporate Finance Report Summary Garden Fresh Restaurants, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Oxford Nanopore Technologies Ltd:企業の戦略的SWOT分析
    Oxford Nanopore Technologies Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Enbridge Inc.:企業の戦略・SWOT・財務情報
    Enbridge Inc. - Strategy, SWOT and Corporate Finance Report Summary Enbridge Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Prologis Inc (PLD):企業の財務・戦略的SWOT分析
    Prologis Inc (PLD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Teledyne Technologies Inc (TDY):企業の財務・戦略的SWOT分析
    Teledyne Technologies Inc (TDY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Canary Wharf Group Plc:企業の戦略・SWOT・財務情報
    Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report Summary Canary Wharf Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nichi-Iko Pharmaceutical Co Ltd (4541):製薬・医療:M&Aディール及び事業提携情報
    Summary Nichi-Iko Pharmaceutical Co Ltd (Nichi-Iko) is a manufacturer of generic products. The company eripheral nervous system medicines. The company offers products such as alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium sulfate, betahis …
  • First Solar Inc (FSLR):電力:M&Aディール及び事業提携情報
    Summary First Solar Inc (First Solar) is a provider of comprehensive photovoltaic (PV) solar systems. It designs, manufactures, and sells PV solar modules. The company produces solar systems using cadmium telluride technology. First Solar also develops, designs, constructs, and sells PV solar power …
  • Milliken & Co:企業の戦略的SWOT分析
    Milliken & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Poupart Limited:企業の戦略・SWOT・財務情報
    Poupart Limited - Strategy, SWOT and Corporate Finance Report Summary Poupart Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • African Phoenix Investments Ltd:企業の戦略・SWOT・財務分析
    African Phoenix Investments Ltd - Strategy, SWOT and Corporate Finance Report Summary African Phoenix Investments Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Innospec Inc (IOSP):企業の財務・戦略的SWOT分析
    Innospec Inc (IOSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Bsquare Corporation (BSQR):企業の財務・戦略的SWOT分析
    Bsquare Corporation (BSQR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • MiMedx Group Inc – Product Pipeline Analysis, 2018 Uate
    Summary MiMedx Group Inc (MiMedx) is a biopharmaceutical company that develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary pur …
  • Gainesville Regional Utilities:企業の戦略的SWOT分析
    Gainesville Regional Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆